Canaccord Positive on Safety Profile of Kite’s Axi-Cel
How Has a Deal Between Kite and Gilead Likewise Sent Juno Shares Jumping?
Greenblatt’s Gotham Management Turns Bullish on These 3 Biotech Stocks
Valeant’s Strengths Are Laced with Challenges Valeant Pharmaceuticals Intl Inc (NYSE:VRX) delivered a sound second-quarter print yesterday before the bell- but the troubled …
Valeant’s Siliq Not Competitive Enough in Psoriasis Market Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) fighting chances in the drug arena to compete may have just …
BTIG analyst Dane Leone sees new reason to step away from the sidelines on Kite Pharma Inc (NASDAQ:KITE), upgrading his rating from a …
Kite Pharma Inc (NASDAQ:KITE) announced that the FDA has accepted for priority review the Biologics License Application (BLA) for axicabtagene ciloleucel. The submission follows …
Valeant Shows Signs of the Stabilization Valeant Pharmaceuticals Intl Inc (NYSE:VRX) investors are finally waking up from their nightmare, as the stock rockets 20% …
Yesterday, drug maker Kite Pharma Inc (NASDAQ:KITE) disclosed the death of a patient who was treated with KTE-C19, the company’s CAR-T blood cancer drug, …
Kite Pharma Inc (NASDAQ:KITE) shares tumbled nearly 13% to $70.99 in Monday’s trading session, after the drug maker announced a grade 5 case …